Stephen Senn Head, Methodology and Statistics Group Competence Center for Methodology and Statistics (CCMS) Luxembourg Responder despondency: myths of personalized medicine The road to drug development destruction is paved with good intentions. The 2013 FDA report, Paving the Way for Personalized Medicine  has an encouraging and enthusiastic foreword from Commissioner Hamburg and plenty of extremely … Continue reading S. Senn: “Responder despondency: myths of personalized medicine” (Guest Post)